JP2024503894A5 - - Google Patents

Info

Publication number
JP2024503894A5
JP2024503894A5 JP2023544048A JP2023544048A JP2024503894A5 JP 2024503894 A5 JP2024503894 A5 JP 2024503894A5 JP 2023544048 A JP2023544048 A JP 2023544048A JP 2023544048 A JP2023544048 A JP 2023544048A JP 2024503894 A5 JP2024503894 A5 JP 2024503894A5
Authority
JP
Japan
Prior art keywords
composition
hpv
use according
cancer
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023544048A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024503894A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/013228 external-priority patent/WO2022159652A1/en
Publication of JP2024503894A publication Critical patent/JP2024503894A/ja
Publication of JP2024503894A5 publication Critical patent/JP2024503894A5/ja
Pending legal-status Critical Current

Links

JP2023544048A 2021-01-21 2022-01-21 粘膜がんを治療するための共生ウイルスに対するｔ細胞誘導性抗がんワクチン Pending JP2024503894A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163140159P 2021-01-21 2021-01-21
US63/140,159 2021-01-21
PCT/US2022/013228 WO2022159652A1 (en) 2021-01-21 2022-01-21 T cell-directed anti-cancer vaccines against commensal viruses for treating mucosal carcinomas

Publications (2)

Publication Number Publication Date
JP2024503894A JP2024503894A (ja) 2024-01-29
JP2024503894A5 true JP2024503894A5 (https=) 2025-01-29

Family

ID=82549772

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023544048A Pending JP2024503894A (ja) 2021-01-21 2022-01-21 粘膜がんを治療するための共生ウイルスに対するｔ細胞誘導性抗がんワクチン

Country Status (4)

Country Link
US (1) US20240100141A1 (https=)
EP (1) EP4281106A4 (https=)
JP (1) JP2024503894A (https=)
WO (1) WO2022159652A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
US9149517B2 (en) * 2007-11-02 2015-10-06 The Johns Hopkins University Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection
JP7688576B6 (ja) * 2018-11-28 2025-07-04 ザ ジェネラル ホスピタル コーポレイション 共生ウイルスに対するｔ細胞指向性抗がんワクチン

Similar Documents

Publication Publication Date Title
JP2025060647A5 (https=)
Pearse et al. ISCOMATRIX® adjuvant for antigen delivery
TWI258374B (en) Vaccine comprising HPV antigens
Garcia-Hernandez et al. Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine
Davis et al. DNA vaccines for viral diseases
de la Garza et al. MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study.
Sundberg et al. Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese Shar Pei dog
JP2003526672A5 (https=)
Zhang et al. Single-walled carbon nanotubes as delivery vehicles enhance the immunoprotective effect of a DNA vaccine against spring viremia of carp virus in common carp
JP2022509221A5 (https=)
AU2002310802B2 (en) Multivalent vaccine comprising an HIV antigen and an HSV antigen and/or an HPV antigen
JP2023518340A5 (https=)
TW200423957A (en) Vaccine
ES2363247T3 (es) Tratamiento para neoplasias intraepiteliales anogenitales inducidas por vph.
AU2002310802A1 (en) Multivalent vaccine comprising an HIV antigen and an HSV antigen and/or an HPV antigen
JP2024503894A5 (https=)
JP2008013537A (ja) Ｐｒｒｓワクチンとしての豚繁殖・呼吸障害症候群ウイルスの融合タンパク質
Huh et al. The future of vaccines for cervical cancer
Karamanou et al. From the humble wart to HPV: a fascinating story throughout centuries
Brun et al. Targeted immunotherapy of high‑grade cervical intra‑epithelial neoplasia: Expectations from clinical trials
US20150110824A1 (en) Method of vaccination against human papillomavirus
JP2008539184A (ja) ワクチン
RU2377305C1 (ru) Мукозальная вакцина для иммунотерапии заболеваний, обусловленных вирусами папилломы человека, и способ лечения с ее использованием (варианты)
Gonçalves et al. Characterization of immunoglobulin A/G responses during 3 doses of the human papillomavirus-16/18 ASO4-adjuvanted vaccine
Majewski et al. Vaccination against human papillomavirus (HPV) as primary prophylaxis of cervical cancer and other lesions induced by HPV